About AEI My AEI Support AEI Contact AEI
Home Events Books Short Publications Research Areas Scholars & Fellows


Search


FindAdvanced Search

Browse all scholars & fellows by:
- Research Area

SCHOLARS & FELLOWS
AEI Research Appointments
Press Releases

E-NEWSLETTERS
Enter e-mail:
 

Home >  Scholars & Fellows >  John E. Calfee >  Events
Events by John E. Calfee
Resident Scholar
Resident Scholar John E. Calfee
[Hide Abstracts]
Off-Label Uses of Approved Drugs: Medicine, Law, and Policy
Wednesday, May 21, 2008
At this AEI Legal Center event, experts on both law and health care will present papers on the law, economics, medicine, and public policy of off-label marketing.
Oncology Drug Development: Rethinking FDA Oversight
Thursday, March 13 - Friday, March 14, 2008
At this conference, a group of experts will delve into such topics as clinical trial design, statistical analysis of trial results, and the feedback process from FDA regulators to pharmaceutical
The Vioxx Settlement
Monday, January 7, 2008
At this cosponsored AEI/Federalist Society event, experts will explore the Vioxx settlement, whether it can bear legal challenge, and the ethical issues surrounding Vioxx litigation?
Vaccinated: The Quest for New Vaccines Yesterday and Today
Tuesday, October 9, 2007
At this event, Offit--through his story of Hilleman’s career--will share his observations on new vaccine development in today’s very different environment, with its threat of liability litigation and
Biotechnology and the Patent System: The Economic Implications of the Proposed Patent Reform Act of 2007
Tuesday, September 25, 2007
The authors will discuss the importance of patents in the development of new biotechnology drugs and diagnostic tests and the recent economic and legal thinking on the dynamics of patent law.
What Should Congress Do about Generic or Follow-On Biologic Drugs?
Monday, June 11, 2007
Panelists will discuss regulation (including in Europe, which already has a follow-on biologic pathway), manufacturing, economics, and intellectual property of biologic drugs.
Can Government Price Negotiation Work for the Medicare Drug Benefit?
Friday, January 19, 2007
Should the government negotiate the prices of pharmaceuticals covered by the new Medicare Part D prescription drug benefit?
Does the United States Need a NICE?
Wednesday, June 28, 2006
At this conference, Andrea Sutcliffe, deputy chief executive of NICE, a group of British and American analysts, and an American biomedical industry representative will examine NICE’s method and its
The Cutter Incident
Friday, April 14, 2006
Paul A. Offit presents his book The Cutter Incident : How America's First Polio Vaccine Led to the Growing Vaccine Crisis.
Medical Malpractice Liability and Physician Supply
Wednesday, April 5, 2006
Do doctors really flee certain states, avoid high-risk specialties such as neurosurgery and obstetrics, or even forgo practicing medicine as a result of ever-growing liability concerns?
Total Records: 47
 [  Next ] 
Research Areas
Advertising
Food and Drug Administration policies
Health care policy
Pharmaceuticals
Tobacco
Tort liability system
Downloads
High-Resolution Photo
Contact Information
John E. Calfee
American Enterprise Institute
 1150 Seventeenth Street, N.W.
Washington, DC  20036
Phone: 202-862-7175
Assistant: 202-862-7183
Fax: 202-862-7177
E-mail: CalfeeJ@aei.org
Latest Book
Biotechnology and the Patent System thumbnail
Biotechnology and the Patent System
This book offers a timely discussion of biotechnology patent reform. [Read More]